Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1143655]Brief description Growing specialized adult stem cells (MSC) in the presence of a unique immune signaling protein (IL-17) has generated a “supercharged” stem cell with superior abilities to dampen immune responses in cell and organ transplant patients. The use of these MSC in transplant patients may significantly reduce the dose of anti-rejection drugs required to prevent cell and organ rejection. By minimizing the dose of drugs, we aim to eliminate the risk of developing infections and cancer in these patients.
Funding Amount $AUD 417,193.32
Funding Scheme Early Career Fellowships
Notes CJ Martin Biomedical ECF
- nhmrc : 1143655
- PURL : https://purl.org/au-research/grants/nhmrc/1143655
